Charles River Laboratories
255 hedge funds and large institutions have $2.79B invested in Charles River Laboratories in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 71 increasing their positions, 135 reducing their positions, and 28 closing their positions.
1,288% more call options, than puts
Call options by funds: $6.13M | Put options by funds: $442K
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
7% more capital invested
Capital invested by funds: $2.6B → $2.79B (+$187M)
0.5% less ownership
Funds ownership: 100.54% → 100.05% (-0.5%)
3% less funds holding
Funds holding: 262 → 255 (-7)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
47% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 135
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$21.2M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$14.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$12.9M |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$10.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$20.4M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$16.4M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$14.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.5M |
| 5 |
Two Sigma Investments
New York
|
-$10.8M |
CRL Hedge Fund Activity: Q3 2014 in Review
255 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2014, worth a combined $2.79B — up 7.2% from $2.6B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CRL and 21 opened new positions — a net loss of 7 holders — while 135 trimmed existing stakes and 71 added.
The largest buyer was Luther King Capital Management (LKCM), opening a new position worth an estimated $21.2M. The largest seller was Norges Bank, cutting an estimated $20.4M.
- 255 institutional investors held Charles River Laboratories (CRL) as of Q3 2014, down from 262 in Q2 2014.
- Funds reported $2.79B of Charles River Laboratories stock for Q3 2014, up 7.2% quarter-over-quarter.
- 21 funds opened new Charles River Laboratories positions in Q3 2014 and 28 closed out, a net change of -7 holders.
- The largest Charles River Laboratories buyer in Q3 2014 was Luther King Capital Management (LKCM), an estimated $21.2M added.
- The largest Charles River Laboratories seller in Q3 2014 was Norges Bank, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2014.